Table of Contents Table of Contents i Introduction 1 1 Definition of The Pharmaceutical Industry 1 2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2 3 Forces of Competition 3 4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4 5 Role of Information Systems & Technology 4 6 GlaxoSmithKline 5 7 United Drug 6 7.1 Company Overview
Premium Pharmaceutical industry Pharmacology Drug discovery
The Global Pharmaceutical Industry Date: 2011 August 20 Table of content Contents Page 1. Introduction 4 2. Pestel analysis of the global pharmaceutical industries 5-6 3. Drivers for change in the future of pharmaceutical 7 4. Five forces analysis on the global pharmaceutical industry 8-10 5. Threats to a big pharmaceutical company 11 6. Conclusion 12 7. Bibliography 13 Introduction The pharmaceutical industry According
Premium Pharmaceutical industry Generic drug Barriers to entry
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
Today the pharmaceutical industry is one of the biggest industries in the United States. The industry experienced a rapid growth rate (in the double digits) in the late 20th century which has now dropped into the single digits (Mullins‚ 2007). The global demand is driven by factors such as a worldwide increase in elderly population and a rising quality of life in developing nations. Time Magazine listed Generic Pharmaceutical Manufacturing as one of the top ten fastest growing industries in the United
Premium Pharmacology Pharmaceutical industry Pharmacy
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
The global pharmaceutical industry 1. Identify the main environmental forces currently affecting the global pharmaceutical industry. The PESTEL analysis can be used to identify the main environmental forces for the industry: Political • Stringent government regulation and powerful purchaser pressures. • Governments around the world focused on pharmaceuticals as a politically easy target in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic
Premium Pharmaceutical industry Generic drug Food and Drug Administration
The Global Pharmaceutical Industry In the pharmaceutical industry market segments can be found depending on the criteria used. For example‚ geographically there are three main market segments (the Triad accounting for 80% and with the strongest growth): The United States of America‚ Europe and Japan with the main future segment being the least developed countries. Another way of classifying the market segments that the pharmaceutical industries face is by those products directed to primary care
Premium Pharmaceutical industry Pharmacology Generic drug
paper will focus on the Diamond Industry and in particular DeBeers’ involvement in shaping the structure of markets and firm conduct within the industry. The paper will examine the influence of DeBeers’ cartel by initially looking at market conditions when DeBeers were operating their cartel‚ then by way of comparison‚ examining the evolvement of the market once the DeBeers cartel was ended‚ effectively opening up the market for the first time. The diamond industry currently produces US$13
Premium Diamond
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
1. Overview of the global pharmaceutical industry In 2003‚ Britain’s Guardian newspaper commented that‚ “on the face of it‚ the global pharmaceutical industry looks like the epitome of a modern‚ mature industry that has found a comfortable way to make profits by the billion: it ’s global‚ hi-tech‚ and has the ultimate customer‚ the healthcare budgets of the world ’s richest countries.” Guardian sept 2003 The global pharmaceutical industry is nowadays made up of thousands of companies contained
Premium Generic drug Pharmaceutical industry Pharmacology